intravitreal, VEGF Therapy, macula

CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Digital Supplements

Icon ImageAddressing Sub-optimal Response During the Treatment of Wet AMD
Supported By: An unrestricted educational grant from Regeneron

Highlights from a roundtable discussion - Part 2 of 2
  
Icon ImageThe Impact of Anti-VEGF Treatments on Naive AMD Patients
Supported By: An unrestricted educational grant from Regeneron

How to choose an agent that is right for your patient.
  
Icon ImageMulti-modality Treatment Approaches to RVO-associated Macular Edema
Expert insights into the importance of utilizing all of the available options
  
Icon ImageInsights on Switching Anti-VEGF Agents for Optimal AMD Treatment
Sponsored By: An unrestricted educational grant from Regeneron Pharmaceuticals

Faculty: Moderator: Peter K. Kaiser, MD
Panelists: Justis Ehlers, MD; Seenu Hariprasad, MD; Atul Jain, MD; Jason Slakter, MD

Highlights of a roundtable discussion held during the 2013 meeting of the Association for Research in Vision and Ophthalmology (AVRO)
  
Icon ImageA Comprehensive Approach to Treating Retinal Vein Occlusion
Faculty: Pravin U. Dugel, MD; Seenu M. Hariprasad, MD; John W. Kitchens, MD; Michael A. Singer, MD

Experts discuss current thinking, including strategies for managing persistent disease.
  
Icon ImageA Multidisciplinary Approach to Managing Patients With Diabetic Eye Disease
Sponsored By: An unrestricted educational grant from Genentech

Panelists: David S. Boyer, MD, moderator; Victor H. Gonzalez, MD; Yehuda Handelsman, MD; Steven D. Schwartz, MD

Based on a live roundtable discussion with leading Retina Specialists and Endocrinologists
  
Icon ImageNeovascular AMD Updates
Jointly Sponsored By: New York Eye & Ear Infirmary and MedEdicus

Highlights from a roundtable discussion
  
Icon ImageEmerging Concepts in Anti-Vegf Treatments
Sponsored By: An unrestricted educational grant from Regeneron Pharmaceuticals

Faculty: David S. Boyer, MD; David M. Brown, MD; Karl G. Csaky, MD; Jeffrey S. Heier, MD

• Recap of expert roundtable panel
• Highlights from key ASRS presentations
• Case studies
  
Icon ImageClinical Perspectives and Considerations With Retisert® (fluocinolone acetonide intravitreal implant)
Sponsored By: Bausch + Lomb

Presenters: Quan Dong Nguyen, MD, MSc, Panel Chair David G. Callanan, MD Debra A. Goldstein, MD, FRCSC Dean Eliott, MD Peter A. Netland, MD, PhD David G. Godfrey, MD Sunil K. Srivastava, MD

Clinical Perspectives and Considerations With Retisert® (fluocinolone acetonide intravitreal implant) 0.59 mg in the Management of Chronic Non-infectious Uveitis of the Posterior Segment: Expertise Beyond the 3-year Follow-up Clinical Trial Data
  
Icon ImageFluocinolone Implant for Idiopathic Non-Infectious Posterior Uveitis
Presented By: Bausch + Lomb

Dr. Brian Berger illustrates how a fluocinolone implant may fit into the treatment armamentarium for patients with non-infectious posterior uveitis and help to achieve treatment goals.
  
Icon ImageSurgical Management of Difficult Cases
Sponsored By: Alcon

Faculty: Maria H. Berrocal, MD; Timothy G. Murray, MD, MBA, FACS; Carl D. Regillo, MD, FACS and Wayne Solley, MD

In this supplement surgeons describe what they consider to be the benefits of the CONSTELLATION® Vision System, in particular when performing challenging complex procedures. Includes video highlightsof procedures.
  
Icon ImageCare of Patients with Chronic Noninfectious Posterior Uveitis
Presented By: Bausch + Lomb

For retinal physicians, there is another opportunity to treat a difficult disease. This supplement is edited by a special guest editor, Robert C. Wang, MD, a fellowship-trained expert in the diagnosis and treatment of uveitis.
  
Icon ImageSurgical Experiences with the Stellaris PC System
Sponsored By: Bausch + Lomb

Presenters: Jeffrey S. Heier, MD (moderator); Andrew N. Antoszyk, MD; Kevin J. Blinder, MD; Derek Y. Kunimoto, MD, JD; Asheesh Tewari, MD and Kenneth J. Wald, MD

This new platform gives surgeons true "procedural choice" by providing advanced technology for vitreoretinal surgery and cataract surgery in a single system. A roundtable of surgeons discuss their professional experience with this new system.
  
Icon ImageIntroducing the Stellaris PC Vision Enhancement System
Sponsored By: Bausch + Lomb

Presenters: Carl C. Awh, MD; David R. Chow, MD, FRCSC; Philip Ferrone, MD; Tarek Hassan, MD and Suber S. Huang, MD, MBA

The new combined vitrectomy and phacoemulsification system is the latest innovation from Bausch + Lomb. A panel of renowned surgeons present their experience with this new, innovative system. Digital supplement includes videos of the presentations.
  
Icon ImageStreamlining Your Retina Practice
Sponsored By: Genentech

The introduction of anti-VEGF therapy signaled a new era in retina practice. Learn how busy practices across the country ensure efficient delivery of this breakthrough treatment
  


AWS-#2